Entera Bio Ltd. Research And Development Expense

• Entera Bio Ltd. showed an increase of +33.5% in Research And Development Expense from 2024 to 2025.
• This data is from Entera Bio Ltd.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
• XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 10 years of available data (2016 to 2025), Entera Bio Ltd.'s Research And Development Expense has grown by 126.7%.
• Historical annual values: Fiscal year 2025: $6.00 million | Fiscal year 2024: $4.50 million | Fiscal year 2023: $4.51 million | Fiscal year 2022: $5.85 million | Fiscal year 2021: $6.77 million | Fiscal year 2020: $6.38 million | Fiscal year 2019: $7.20 million | Fiscal year 2018: $8.52 million | Fiscal year 2017: $2.77 million | Fiscal year 2016: $2.65 million.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026